These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1127 related items for PubMed ID: 27889747
1. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, Zhou B. Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [Abstract] [Full Text] [Related]
2. Effects of Eriobotrya japonica Water Extract on Alcoholic and Nonalcoholic Fatty Liver Impairment. Mun J, Park J, Yoon HG, You Y, Choi KC, Lee YH, Kim K, Lee J, Kim OK, Jun W. J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842 [Abstract] [Full Text] [Related]
3. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. Luo L, Fang K, Dan X, Gu M. Lipids Health Dis; 2019 Jan 08; 18(1):11. PubMed ID: 30621686 [Abstract] [Full Text] [Related]
4. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells. Fang K, Wu F, Chen G, Dong H, Li J, Zhao Y, Xu L, Zou X, Lu F. BMC Complement Altern Med; 2019 Sep 13; 19(1):255. PubMed ID: 31519174 [Abstract] [Full Text] [Related]
6. Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway. Ho C, Gao Y, Zheng D, Liu Y, Shan S, Fang B, Zhao Y, Song D, Zhang Y, Li Q. J Cell Mol Med; 2019 Aug 13; 23(8):5108-5118. PubMed ID: 31144451 [Abstract] [Full Text] [Related]
7. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH. World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001 [Abstract] [Full Text] [Related]
8. Isosilybin regulates lipogenesis and fatty acid oxidation via the AMPK/SREBP-1c/PPARα pathway. Liu X, Hu M, Ye C, Liao L, Ding C, Sun L, Liang J, Chen Y. Chem Biol Interact; 2022 Dec 01; 368():110250. PubMed ID: 36347319 [Abstract] [Full Text] [Related]
9. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD). Araújo S, Soares E Silva A, Gomes F, Ribeiro E, Oliveira W, Oliveira A, Lima I, Lima MDC, Pitta I, Peixoto C. Eur J Pharmacol; 2016 Oct 05; 788():306-314. PubMed ID: 27349145 [Abstract] [Full Text] [Related]
10. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. Liu H, Zhong H, Yin Y, Jiang Z. Biomed Pharmacother; 2017 Jul 05; 91():964-969. PubMed ID: 28514835 [Abstract] [Full Text] [Related]
11. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Liu Q, Pan R, Ding L, Zhang F, Hu L, Ding B, Zhu L, Xia Y, Dou X. Int Immunopharmacol; 2017 Aug 05; 49():132-141. PubMed ID: 28577437 [Abstract] [Full Text] [Related]
12. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice. López-Oliva ME, Garcimartin A, Muñoz-Martínez E. Br J Nutr; 2017 Dec 05; 118(11):914-929. PubMed ID: 29173234 [Abstract] [Full Text] [Related]
13. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Seo MS, Kim JH, Kim HJ, Chang KC, Park SW. Toxicol Appl Pharmacol; 2015 Apr 15; 284(2):113-24. PubMed ID: 25737164 [Abstract] [Full Text] [Related]
14. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα). Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, Zhang DH. Eur J Pharmacol; 2013 Aug 15; 714(1-3):89-95. PubMed ID: 23791610 [Abstract] [Full Text] [Related]
15. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM. Food Chem Toxicol; 2014 Feb 15; 64():94-103. PubMed ID: 24275089 [Abstract] [Full Text] [Related]
16. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, Xia M, Chang X, Lu Y, Li Y, Xia P, Li X, Gao X. Free Radic Biol Med; 2019 Sep 15; 141():192-204. PubMed ID: 31226399 [Abstract] [Full Text] [Related]
17. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells. Yoon S, Kim J, Lee H, Lee H, Lim J, Yang H, Shin SS, Yoon M. J Ethnopharmacol; 2017 Jan 04; 195():204-213. PubMed ID: 27845265 [Abstract] [Full Text] [Related]
18. Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts. Schindler M, Pendzialek M, Grybel KJ, Seeling T, Gürke J, Fischer B, Navarrete Santos A. Hum Reprod; 2017 Jul 01; 32(7):1382-1392. PubMed ID: 28472298 [Abstract] [Full Text] [Related]
19. Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways. Chen KY, Lin JA, Yao HY, Hsu AC, Tai YT, Chen JT, Hsieh MC, Shen TL, Hsu RY, Wu HT, Wang GH, Ho BY, Chen YP. Nutr Res; 2018 Apr 01; 52():87-97. PubMed ID: 29525610 [Abstract] [Full Text] [Related]
20. Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role. Mi Y, Tan D, He Y, Zhou X, Zhou Q, Ji S. Cell Biochem Biophys; 2018 Dec 01; 76(4):463-470. PubMed ID: 30324559 [Abstract] [Full Text] [Related] Page: [Next] [New Search]